BUY MBP VINBLASTIN CYTOBLASTIN 10MG INJ. VIAL BEST PRICE ONLINE IN NIGERIA LAGOS ABUJA KANO AND PORTHARCOURT AT MYBIGPHARMACY.COM

Description

Dear friend, this medication requires a prescription or medical license before it can be delivered to you. kindly ensure that you provide us with a reliable contact information at checkout, mybigpharmacy team will be in touch with you to obtain required document before your order is confirmed thank you for trusting mybig pharmacy with your health. Vinblastine is a chemotherapy medicine used to treat several types of cancer, particularly Hodgkin lymphoma, non-Hodgkin lymphoma, testicular cancer, breast cancer, Kaposi?s sarcoma, and certain childhood cancers. It belongs to a group of medicines called vinca alkaloids, which are derived from the periwinkle plant. Vinblastine works by stopping cancer cells from dividing and multiplying.

Vinblastine works by interfering with structures inside the cell called microtubules. These structures are essential for cell division. By preventing microtubules from forming properly, vinblastine stops cancer cells from completing cell division, which leads to cell death. Because cancer cells divide more rapidly than normal cells, they are more affected by this action, although some healthy cells can also be affected.

Vinblastine is given by intravenous injection only and must be administered by trained healthcare professionals. It must never be given into the spinal canal, as this can be fatal. The dose is carefully calculated based on body size, blood test results, and the specific treatment protocol being used. It is often given as part of a combination chemotherapy regimen rather than on its own.

One of the most important side effects of vinblastine is bone marrow suppression. This can lead to low white blood cell counts, increasing the risk of infection; low red blood cell counts, causing fatigue and shortness of breath; and low platelet counts, increasing the risk of bruising or bleeding. Because of this, regular blood tests are essential during treatment.

Common side effects of vinblastine include nausea, vomiting, constipation, abdominal cramps, fatigue, hair thinning or hair loss, and mouth sores. Constipation can sometimes be severe, so patients are often advised to maintain good hydration, eat fibre-rich foods, and use stool softeners if needed.

Vinblastine can also affect the nervous system, although less commonly than some related medicines. Symptoms may include numbness, tingling, muscle weakness, or jaw pain. These symptoms should be reported promptly, especially if they worsen.

If vinblastine leaks outside the vein during administration, it can cause severe tissue damage. For this reason, healthcare professionals closely monitor the injection site during administration. Any pain, swelling, or burning sensation should be reported immediately.

Vinblastine may cause changes in blood pressure and can occasionally affect liver function, so regular monitoring is important. Patients may also experience increased susceptibility to infections due to reduced immune function.

Vinblastine should not be used during pregnancy, as it can cause serious harm to the unborn baby. Effective contraception is required during treatment and for a period after therapy ends. Breastfeeding is also not recommended while receiving vinblastine.

Patients should avoid close contact with people who have infections and should report symptoms such as fever, sore throat, unusual bruising, or bleeding immediately. Vaccinations with live vaccines should be avoided during treatment.

Although vinblastine can cause significant side effects, it remains an important and effective chemotherapy medicine. When used correctly under specialist supervision, it plays a key role in treating several types of cancer and improving patient outcomes.